SHINYA YAMAMOTO to Retrospective Studies
This is a "connection" page, showing publications SHINYA YAMAMOTO has written about Retrospective Studies.
Connection Strength
0.176
-
Retreatment or prolonged antiviral therapy in severe acute respiratory syndrome Coronavirus-2 infection among immunocompromised patients during 2022-2023: A nationwide claims-based cohort study in Japan. J Infect Chemother. 2025 Nov; 31(11):102830.
Score: 0.064
-
Clinical impact of the use of chronic suppressive antibiotics against recurrent ventricular assist device infections. Microbiol Spectr. 2024 11 05; 12(11):e0039824.
Score: 0.059
-
Significance of Nontuberculous Mycobacteria Detection in Liver Transplant Recipients: A Descriptive Epidemiology. Transplant Proc. 2026 Oct; 58(8):1557-1561.
Score: 0.017
-
Prognostic significance of body mass index in patients with metastatic renal cell carcinoma receiving first-line therapies. Urol Oncol. 2025 04; 43(4):269.e1-269.e6.
Score: 0.015
-
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study. Int J Clin Oncol. 2024 Apr; 29(4):398-406.
Score: 0.014
-
Intraoperative red cell salvage during obstetric surgery in 50 Japanese women. Int J Gynaecol Obstet. 2015 Mar; 128(3):256-9.
Score: 0.007